Rigel Pharmaceuticals (RIGL) Net Income Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Rigel Pharmaceuticals | 551.62 Mn | 404.94 Mn | 54.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.19% |
| Dec 31, 2025 | 73.97% |
| Sep 30, 2025 | 31.74% |
| Jun 30, 2025 | 40.07% |
| Mar 31, 2025 | -11.63% |
| Dec 31, 2024 | 23.16% |
| Sep 30, 2024 | 25.24% |
| Jun 30, 2024 | 45.08% |
| Mar 31, 2024 | 14.07% |
| Dec 31, 2023 | -25.58% |
| Sep 30, 2023 | 24.86% |
| Jun 30, 2023 | 23.72% |
| Mar 31, 2023 | 11.11% |
| Dec 31, 2022 | 15.49% |
| Sep 30, 2022 | -1.51% |
| Jun 30, 2022 | 6.76% |
| Mar 31, 2022 | -11.33% |
| Dec 31, 2021 | -7.59% |
| Sep 30, 2021 | 1.53% |
| Jun 30, 2021 | -0.38% |
| Mar 31, 2021 | 33.63% |
| Dec 31, 2020 | -8.68% |
| Sep 30, 2020 | -16.07% |
| Jun 30, 2020 | -4.79% |
| Mar 31, 2020 | 25.94% |
| Dec 31, 2019 | 5.08% |
| Sep 30, 2019 | 11.35% |
| Jun 30, 2019 | 4.09% |
| Mar 31, 2019 | 4.63% |
| Dec 31, 2018 | 16.99% |
| Sep 30, 2018 | 0.05% |
| Jun 30, 2018 | -2.34% |
| Mar 31, 2018 | 0.95% |
| Dec 31, 2017 | -0.30% |
| Sep 30, 2017 | 7.05% |
| Jun 30, 2017 | 4.99% |
| Mar 31, 2017 | 7.09% |
| Dec 31, 2016 | 9.47% |
| Sep 30, 2016 | -4.76% |
| Jun 30, 2016 | 8.82% |
| Mar 31, 2016 | 3.42% |
| Dec 31, 2015 | 8.33% |
| Sep 30, 2015 | -16.36% |
| Jun 30, 2015 | -20.25% |